Icure Pharmaceutical Incorporation's latest marketcap:
As of 06/26/2025, Icure Pharmaceutical Incorporation's market capitalization has reached $57.31 M. According to our data, Icure Pharmaceutical Incorporation is the 28587th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 57.31 M |
| Revenue (ttm) | 55.19 M |
| Net Income (ttm) | 2.51 M |
| Shares Out | 37.37 M |
| EPS (ttm) | 0.07 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 08/14/2025 |
Icure Pharmaceutical Incorporation's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | ₩57.31 M | 4.3% | 28587 |
| 12/30/2024 | ₩67.83 B | -13.16% | 28656 |
| 12/28/2023 | ₩78.1 B | -1.76% | 26523 |
| 12/29/2022 | ₩79.5 B | -76.54% | 25338 |
| 12/30/2021 | ₩338.83 B | -27.49% | 16794 |
| 12/30/2020 | ₩467.31 B | 100.53% | 12422 |
| 12/30/2019 | ₩233.04 B | 15.15% | 14761 |
| 12/28/2018 | ₩202.38 B | 14414 |
Company Profile
About Icure Pharmaceutical Incorporation
Icure Pharmaceutical Incorporation is a biopharmaceutical company specializing in the research, development, and sale of pharmaceutical and cosmetic products. Headquartered in Seoul, South Korea, the company was established in 2000.
Product Offerings
Icure provides a diverse range of high-quality cosmetic and pharmaceutical solutions, including:
- Cosmetics: Functional, nature-derived, derma, and customized cosmetic products.
- Skincare Solutions: Eye gel, hydro nude gel, lip gel mask, and functional patches.
- Masks: Sheet, mud, foil, and melting masks for various skincare needs.
- Body & Haircare: Naturally derived hair and baby line products, cleansing tissues, and wet wipes.
- Fragrances: Perfumes, textile perfumes, body mists, and hair/body fragrances.
With a commitment to innovation and quality, Icure Pharmaceutical Incorporation continues to expand its portfolio to meet evolving consumer demands.
Frequently Asked Questions
-
What is Icure Pharmaceutical Incorporation's (KOSDAQ-175250) current market cap?As of 06/26/2025, Icure Pharmaceutical Incorporation (including the parent company, if applicable) has an estimated market capitalization of $57.31 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Icure Pharmaceutical Incorporation (KOSDAQ-175250) rank globally by market cap?Icure Pharmaceutical Incorporation global market capitalization ranking is approximately 28587 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.